Literature DB >> 18688870

Vertical transmission of a mutation in exon 1 of the WT1 gene: lessons for genetic counseling.

Miriam Regev1, Richard Kirk, Maya Mashevich, Zvi Bistritzer, Orit Reish.   

Abstract

We present a vertical transmission of a nonsense mutation in exon 1 of the Wilms' tumor WT1 gene, from a mother who had Wilms' tumor in infancy and decreased fertility at adulthood, to her son who displayed genitourinary (GU) anomalies, gonadal dysgenesis with gonadoblastoma foci, and intra-abdominal Mullerian derivatives. No Wilms' tumor was detected up to the age of 6 years in the son. Sequence analysis of constitutional DNA of the WT1 gene revealed a heterozygous c.327C > A sequence change in exon 1 leading to a premature stop codon at amino acid 109. This mutation demonstrates the lack of correlation between genotype-phenotype and mutation position in the WT1 gene, the presence of intra-familial variability, and the effect of gender on severity of GU anomalies. We suggest that detection of a GU defect in the presence of parental history of Wilms' tumor be followed up by screening of constitutional DNA for WT1 mutations. Explorative laparoscopy for sex organ evaluation and gonadal assessment for possible gonadoblastoma should be considered when constitutional mutation is detected in males with GU anomalies. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688870     DOI: 10.1002/ajmg.a.32330

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  A novel WT1 gene mutation in a three-generation family with progressive isolated focal segmental glomerulosclerosis.

Authors:  Elisa Benetti; Gianluca Caridi; Cristina Malaventura; Monica Dagnino; Emanuela Leonardi; Lina Artifoni; Gian Marco Ghiggeri; Silvio C E Tosatto; Luisa Murer
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 8.237

2.  A familial WT1 mutation associated with incomplete Denys-Drash syndrome.

Authors:  Chunhua Zhu; Fei Zhao; Weizhen Zhang; Hongmei Wu; Ying Chen; Guixia Ding; Aihua Zhang; Songming Huang
Journal:  Eur J Pediatr       Date:  2013-05-29       Impact factor: 3.183

3.  19q13.11 cryptic deletion: description of two new cases and indication for a role of WTIP haploinsufficiency in hypospadias.

Authors:  Simone Gana; Pierangelo Veggiotti; Giusy Sciacca; Cristina Fedeli; Anna Bersano; Giuseppe Micieli; Mohamad Maghnie; Roberto Ciccone; Elena Rossi; Katie Plunkett; Weimin Bi; Vernon R Sutton; Orsetta Zuffardi
Journal:  Eur J Hum Genet       Date:  2012-02-29       Impact factor: 4.246

4.  Cutis Aplasia as a clinical hallmark for the syndrome associated with 19q13.11 deletion: the possible role for UBA2 gene.

Authors:  Joana B Melo; Alexandra Estevinho; Jorge Saraiva; Lina Ramos; Isabel M Carreira
Journal:  Mol Cytogenet       Date:  2015-03-26       Impact factor: 2.009

5.  A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation.

Authors:  Y Kaneko; H Okita; M Haruta; Y Arai; T Oue; Y Tanaka; H Horie; S Hinotsu; T Koshinaga; A Yoneda; Y Ohtsuka; T Taguchi; M Fukuzawa
Journal:  Br J Cancer       Date:  2015-03-17       Impact factor: 7.640

6.  Exonic WT1 pathogenic variants in 46,XY DSD associated with gonadoblastoma.

Authors:  Sneha Arya; Sandeep Kumar; Anurag R Lila; Vijaya Sarathi; Saba Samad Memon; Rohit Barnabas; Hemangini Thakkar; Virendra A Patil; Nalini S Shah; Tushar R Bandgar
Journal:  Endocr Connect       Date:  2021-11-25       Impact factor: 3.335

7.  Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome.

Authors:  Hugh J McCarthy; Agnieszka Bierzynska; Matt Wherlock; Milos Ognjanovic; Larissa Kerecuk; Shivaram Hegde; Sally Feather; Rodney D Gilbert; Leah Krischock; Caroline Jones; Manish D Sinha; Nicholas J A Webb; Martin Christian; Margaret M Williams; Stephen Marks; Ania Koziell; Gavin I Welsh; Moin A Saleem
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-24       Impact factor: 8.237

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.